S Weijzen, SC Meredith, MP Velders, AG Elmishad, H Schreiber, WM Kast. (2001) " Pharmacokinetic differences between a T cell-tolerizing and a T cell-activating peptide. " J Immunol 166. 7151-7 PMID: 11390461 | Abstract and Keywords
TK Hoffmann, DJ Loftus, K Nakano, MJ Maeurer, K Chikamatsu, E Appella, TL Whiteside, AB DeLeo. (2002) " The ability of variant peptides to reverse the nonresponsiveness of T lymphocytes to the wild-type sequence p53(264-272) epitope. " J Immunol 168. 1338-47 PMID: 11801674 | Abstract and Keywords
LT Nguyen, AR Elford, K Murakami, KM Garza, SP Schoenberger, B Odermatt, DE Speiser, PS Ohashi. (2002) " Tumor growth enhances cross-presentation leading to limited T cell activation without tolerance. " J Exp Med 195. 423-35 PMID: 11854356 | Abstract and Keywords
D Zhang, P Shankar, Z Xu, B Harnisch, G Chen, C Lange, SJ Lee, H Valdez, MM Lederman, J Lieberman. (2003) " Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic. " Blood 101. 226-35 PMID: 12393740 DOI: 10.1182/blood-2002-03-0791 | Abstract and Keywords
SW McPherson, J Yang, CC Chan, C Dou, DS Gregerson. (2003) " Resting CD8 T cells recognize beta-galactosidase expressed in the immune-privileged retina and mediate autoimmune disease when activated. " Immunology 110. 386-96 PMID: 14632667 | Abstract and Keywords
F Melchionda, MK McKirdy, F Medeiros, TJ Fry, CL Mackall. (2004) " Escape from immune surveillance does not result in tolerance to tumor-associated antigens. " J Immunother 27. 329-38 PMID: 15314541 | Abstract and Keywords